Local Versus Systemic Treatment for Primary Cutaneous B-Cell Lymphoma

被引：0
作者：
Zinzani, Pier Luigi [1 ]
Argnani, Lisa [1 ]
Broccoli, Alessandro [1 ]
机构：
[1] Univ Bologna, Inst Hematol & Med Oncol LeA Seragnoli, I-40138 Bologna, Italy
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2010年 / 10卷
关键词：
CBCL; Diffuse large B-cell lymphoma; Primary cutaneous follicle center lymphoma; Primary cutaneous marginal zone B-cell lymphoma; ANTI-CD20; MONOCLONAL-ANTIBODY; WHO-EORTC CLASSIFICATION; MARGINAL ZONE LYMPHOMA; TREATMENT-OF-CANCER; COMPLETE REMISSION; INTERFERON ALPHA-2A; INTRALESIONAL THERAPY; BORRELIA-BURGDORFERI; MYCOSIS-FUNGOIDES; SEZARY-SYNDROME;
D O I：
10.3816/CLML.2010.s.020
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：S103 / S105
页数：3
相关论文
共 41 条
  • [1] Primary cutaneous follicular B-cell lymphoma arising at the site of radiotherapy for breast cancer
    Bachmeyer, C.
    Khosrotehrani, K.
    Moguelet, P.
    Aractingi, S.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2007, 156 (01) : 198 - 199
  • [2] Strong expression of FOXP1 identifies a distinct subset of diffuse large B-cell lymphoma (DLBCL) patients with poor outcome
    Barrans, SL
    Fenton, JAL
    Banham, A
    Owen, RG
    Jack, AS
    [J]. BLOOD, 2004, 104 (09) : 2933 - 2935
  • [3] Complete remission of a primary cutaneous B-cell lymphoma of the lower leg by first-line monotherapy with the CD20-antibody rituximab
    Bonnekoh, B
    Schulz, M
    Franke, I
    Gollnick, H
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2002, 128 (03) : 161 - 166
  • [4] Primary cutaneous large-cell lymphoma: analysis of 49 patients included in the LNH87 prospective trial of polychemotherapy for high-grade lymphomas
    Brice, P
    Cazals, D
    Mounier, N
    Verola, O
    Neidhart-Berard, AM
    Remenieras, L
    Deconinck, E
    Doyen, C
    Hamelsand, J
    Molina, T
    Moulonguet, I
    Gisselbrecht, C
    [J]. LEUKEMIA, 1998, 12 (02) : 213 - 219
  • [5] Infection by Borrelia burgdorferi and cutaneous B-cell lymphoma
    Cerroni, L
    Zochling, N
    Putz, B
    Kerl, H
    [J]. JOURNAL OF CUTANEOUS PATHOLOGY, 1997, 24 (08) : 457 - 461
  • [6] De Sanctis V, 2007, ANTICANCER RES, V27, P601
  • [7] Pegylated liposomal doxorubicin as single-agent treatment of low-grade non-Hodgkin's lymphoma: A phase II multicenter study
    Di Bella, NJ
    Khan, MM
    Dakhil, SR
    Logie, KW
    Marsland, TA
    Weinstein, RE
    Mirabel, MY
    Asmar, L
    [J]. CLINICAL LYMPHOMA, 2003, 3 (04): : 235 - 240
  • [8] Systemic therapy with cyclophosphamide and anti-CD20 antibody (rituximab) in relapsed primary cutaneous B-cell lymphoma: A report of 7 cases
    Fierro, MT
    Savoia, P
    Quaglino, P
    Novelli, M
    Barberis, M
    Bernengo, MG
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2003, 49 (02) : 281 - 287
  • [9] Treatment of primary cutaneous B-cell lymphoma with rituximab
    Fink-Puches, R
    Wolf, IH
    Zalaudek, I
    Kerl, H
    Cerroni, L
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2005, 52 (05) : 847 - 853
  • [10] Systemic eight-cycle anti-CD20 monoclonal antibody (rituximab) therapy in primary cutaneous B-cell lymphomas - an applicational observation
    Gellrich, S
    Muche, JM
    Wilks, A
    Jasch, KC
    Voit, C
    Fischer, T
    Audring, H
    Sterry, W
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2005, 153 (01) : 167 - 173
12345